Profile Picture

Naveen Kulkarni - Profile

Naveen Kulkarni, Designated Partner and Director, with 9 companies across 1 industry.

About Naveen Kulkarni

Naveen Kulkarni has 22 years in corporate governance. Holds Designated Partner and Director roles. Currently with 4 companies, including Quantumzyme Llp and Polyclone Lifesciences Private Limited. Formerly with 5 companies, such as Cryo Stemcell Private Limited and Cryo Stemcell Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 4
Past Companies 5
Total Affiliations 9
Oldest Company Age 22
Companies Associated with Naveen Kulkarni
Current Companies
Previous Companies

Dishem Llp

Founded: 2016

Status: Strike Off

Designation: Designated Partner

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Naveen Kulkarni?

Naveen Kulkarni has 22 years in corporate governance. Holds Designated Partner and Director roles. Currently with 4 companies, including Quantumzyme Llp and Polyclone Lifesciences Private Limited. Formerly with 5 companies, such as Cryo Stemcell Private Limited and Cryo Stemcell Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Naveen Kulkarni's role in current companies?

Naveen Kulkarni is associated with 4 companies as Designated Partner and Director.

What industries does Naveen Kulkarni specialize in?

Naveen Kulkarni has expertise in General Business.

How many years of experience does Naveen Kulkarni have?

Naveen Kulkarni has 22 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available